Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A study conducted by neuroscientists at the Massachusetts Institute of Technology has looked at a new kind of drug that may be beneficial for people suffering from post-traumatic stress disorder.
Examples of the kind of traumatic events people with PTSD might have experienced include military combat, sexual assault, natural disasters (such as earthquakes or floods) or serious road accidents.
Not everyone who goes through a distressing event will get PTSD, but we know that it is common - nearly 20% of Vietnam veterans experienced PTSD after the war.
People who do have PTSD will usually be treated with psychotherapy. This is a talking therapy where the patient will talk through their experience with a trained therapist, with the goal of understanding and eventually overcoming their fear.
Psychotherapy does not always work, though, especially if the trauma the patient experienced occurred a long time ago. Doctors think this is because the traumatic experience becomes too "entrenched" in the patient's memory.
The Massachusetts Institute of Technology (MIT) neuroscientists wanted to see if they could "extinguish" traumatic memories using a drug treatment. They tested a drug called a HDAC2 inhibitor - which is normally used to treat cancer - to see if the drug could remove fearful memories in mice.
To test this, the researchers first instilled a fear in the mice of a specific chamber in their habitat by administering a weak electric shock to their feet when they entered that chamber.
The researchers found that they could train the mice to overcome their fear of the chamber if they placed them within the chamber without administering the electric shock. But this only worked on mice whose memories of the electric shock were 24 hours old.
A second group of mice whose memories of the shock were 30 days old could not be trained to overcome their fear of the chamber.
Li-Huei Tsai, the director of MIT's Picower Institute for Learning and Memory, says:
"If you do something within this window of time, then you have the possibility of modifying the memory or forming a new trace of memory that actually instructs the animal that this is not such a dangerous place. However, the older the memory is, the harder it is to really change that memory."
So the researchers decided to reduce the HDAC2 protein in the fearful mice using the HDAC2 inhibitors. When they did so, they found that the mice could be trained to overcome their 30-day-old fears of the chamber.
Publishing their findings in the journal Cell, the researchers think this explains the molecular reasons why older traumatic memories are harder to overcome than newer memories.
The researchers also noticed that the HDAC2 inhibitor drug seemed to "switch-on" genes that aid memory formation, and cause increased activity in the hippocampus of these mice - the area of the brain where memories are formed.
Prof. Tsai told Medical News Today that she hopes HDAC2 inhibitors will be investigated as a potential treatment for PTSD, phobias and anxiety disorders in humans:
"If there is no safety issue, I think HDAC2 inhibitors can be used in conjunction with psychotherapy as the first line treatment, as the combo enables much more efficient fear memory extinction, especially for the long-term, remote memories."
Written by David McNamee
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Study identifies drug that could improve treatment of PTSD, MIT News Office, accessed 15 January 2014.
Information from National Institute of Mental Health, accessed 15 January 2014.
Visit our Psychology / Psychiatry category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
McNamee, David. "Could a memory-rewriting drug help treat PTSD?." Medical News Today. MediLexicon, Intl., 17 Jan. 2014. Web.
12 Mar. 2014. <http://www.medicalnewstoday.com/articles/271283>
McNamee, D. (2014, January 17). "Could a memory-rewriting drug help treat PTSD?." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/271283.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.